The Harley Street Journal

Bi-monthly newspaper for the cosmetic and plastic surgery sector

Uncategorized

Lunchtime liquid nose jobs are the new filler craze

by

According to a cosmetic doctor patients are shunning surgical nose reshaping procedures in favour of a 15-minute liquid nose job.

Dr Naomi McCullum, founder of The Manse Clinic, says she’s seen a steep rise in enquiries and credits the procedure’s popular with the ability to “fix a flaw so quickly”.

She said: The treatment involves injecting filler into the nose to change its shape and costs around a tenth of the price of a full-blown rhinoplasty.

“It can be much more precise than a surgical rhinoplasty and is often used to improve defects after surgical rhinoplasty.

“It’s a different world to 10 years ago for the injectable industry because of social media.”

Advanced Esthetics Solutions announced as UK distributor for Noon Aesthetics products

by

Advanced Esthetics Solutions is proud to be announced as the sole UK distributor in the UK of Noon Aesthetics products.

The Cardiff-based aesthetics company behind the top-selling Lipofirm Pro platform will be providing the skin care products B2B to practitoners and healthcare professionals online from June. 

Noon skin care products offer high concentration with low irritation and include products for all skin types. 

As well as products to help reduce acne and problematic skin concerns the range consists of cleansers, peels, masks and hydrating moisturisers. 

The range is only available to buy by professionals and is designed to help improve and boost the overall service provided in clinic. 

The product line provides solutions and impressive results for various skin problems, such as aging skin, sun damage, hyper-pigmentation, loss of elasticity, acne and more. 

The line includes professional products with high concentration levels of active ingredients, which effectively treat the skin without unwanted side effects such as irritation, burning, redness and discomfort, due to the use of our DermShield™ technology.

Douglas Sykes, Managing Director of Advanced Esthetics Solutions says the launch of Noon was a proud moment for the team at AES.

“We’re delighted to be the sole UK distributor of Noon Aesthetics products in the UK, and we look forward to showcasing all the benefits of this skincare range,” he says.

“The pharmaceutical range mirrors the same values as we do at AES, with a focus on science-based results and proven reliability.

“We continue to grow and diversify as a company and this feels like a great fit for us as we evolve. Our team is thrilled to be working on this and showing our customers the benefits of our complete portfolio of products – from skincare like this to energy assisted platforms.”

A new UK focused trade website is due to be launched this month to coincide with the official launch.

For more information please contact the Advanced Esthetics Solutions team on 029 2023 1228 or info@advancedestheticssolutions.co.uk

COSMETIC INJECTABLES – THE NEW PIP CRISIS WAITING TO HAPPEN?

by

·      Pharmacist calls for industry regulation over how fillers are bought, sold and used in the UK

·      ‘Wild West’ epidemic inevitable unless changes are made from within the industry but needs consumer focus

·      PIP-style crisis waiting to happen, is the stark warning issued, with more corrections being carried out than ever

An online pharmacy has called for an urgent review on how cosmetic injectables are supplied to healthcare professionals – and in turn often vulnerable patients.

Regulation has not been achieved despite BAAPS efforts to regulate an industry often refereed to as ‘the Wild West’.

Springpharm, a UK based online pharmacy for healthcare professionals is championing a new way to regulate the industry – not by individual practitioners, but to (controversially) blow the lid on the supply chain servicing it. 

Andrew Burr from Springpharm says there are 5 core areas that need addressing:

1.    Unqualified users

2.    Remote prescribing

3.    Cross contamination

4.    Parallel imports (storage and efficacy of products) and fake products

5.    Mislicenced products

Andrew believes addressing these five things can bring about safety for consumers undergoing cosmetic skin rejuvenation treatments, who are often being mistreated and misinformed

So what next? 

Andrew says: “If we continue as an industry to ignore the elephant in the room we are effectively complicit in the next PIP style scandal. As history teaches us, healthcare professionals will not be held accountable – but ignorance is not an excuse. 

“At Springpharm we have had enough and believe it’s time for a change. This new year we want new regulations to protect patients, but we want patients to protect themselves too by demanding change.”

In order to lead the injectables industry in changing its fundamental offerings, Springpharm has implemented measures for transparency:

– They have a two-tier prescription process in place to eliminate forged prescriptions for multiple use; this stops things like Botox parties in kitchens by removing the ability to use a prescription numerous times

– They only sell products to registered healthcare professionals

– The prescriptions are named for the patients specifically, not the doctor/nurse

So what can patients do to make themselves safer? Andrew suggestions they take the following steps:

– Firstly choose a reputable expert that’s regulated by an official body. Ask to see qualifications. 

– Make sure your products has your name on the box; ask to see the label before treatment

– Check the intended use/licence for the specific product you’re offered; not all injectables can be used all over the face, as example.

– Ask where the product originated from

BTL Vanquish receives FDA clearance for waistline inch loss

by

Words by Rosie Wilson

BTL’s fat-reduction system Vanquish has been awarded FDA clearance for reducing the circumference of the waistline. The patented technology, which is the only completely contactless inch loss device on the market, uses thermal energy blended with unique cooling technology to cause fat loss whilst protecting the skin and ensuring patient comfort.

The technology, which has already been adapted for successful use on the thighs, has now received affirmation of its successful treatment of the abdomen.

David McDaniel, MD, is a leading dermatologist in the USA and an investigator of high-tech devices for non-surgical body contouring. He said:

“BTL Vanquish is truly a breakthrough technology. Published clinical studies show it permanently destroys unwanted fat for safe and measurable circumferential reduction of the abdominal area without the cost and inconvenience of surgery. FDA clearance of Vanquish is a significant step forward in providing the newest treatment option for body slimming and shaping.”

And the BTL’s Director of Clinical Development, Andrea Morrison, said:

“FDA clearance of BTL Vanquish marks a defining moment in our journey to provide physicians and their patients an elegant treatment option to target fat cells and bring about a reduction in the waist circumference.

“BTL is proud to offer patients a comfortable, affordable and non-invasive body shaping experience. This regulatory milestone underscores BTL’s commitment to deliver meaningful solutions to aesthetic patient care.”

For more information on BTL’s Vanquish, visit www.btlaesthetics.com/en/vanquish

BTL and Zeltiq Lawsuit Update

by

10096026_xxlOn March 25, 2014 the United States Magistrate Judge in Northern California DENIED the Motion for Preliminary Injunction, filed by Zeltiq Aesthetics against BTL Industries.

In the action, Zeltiq alleged that BTL falsely advertised its Vanquish device, causing “irreparable harm” to Zeltiq in the US.

The trial for permanent injunction has now been set for June 15, 2015.

International Symposium of Facial Plastic Surgery in New York

by

7961111_xxlThe American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) will celebrate its 50th anniversary at the 11th International Symposium of Facial Plastic Surgery- and surgeons from all over the UK will be there representing the industry.
Every four years, the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) and the International Federation of Facial Plastic Surgery Societies (IFFPSS) host an international symposium that brings together facial plastic surgeons from all over the world and in the specialties of facial plastic surgery, oculoplastic surgery, dermatologic surgery, plastic and cosmetic surgery.

The New York gathering features the latest trends and technologies in facial plastic and cosmetic surgery. It’s a mixture of lectures, panels, workshops and instruction courses led by leaders in the field followed by an exhibition of hundreds of companies showcasing and introducing their latest products and services.

Mr Aftab Ahmed, an ENT Surgeon based in Doncaster, said attending the event will be an insightful and important date for his busy diary.

“I am thrilled to be representing the UK at this unique conference,” he said.

“It’s important that we carry on learning and understanding the latest techniques and treatments on offer in order to offer patients the best procedures and the finest results,” he concluded.

The conference will take place May 27th-31st at the New York Marriott Marquis.

Lifestyle Aesthetics Launch iRejuvenation

by

10177782_xxlLifestyle Aesthetics have launched iRejuvenation, a secured, ergonomic and reliable solution to report, present and share patients cosmetic timeline from first injection through their ongoing treatment plan.

According to the Swindon-based company, iRejuvenation handles the entire cosmetic workflow, and patient consent, medical pictures, injection procedures, reporting and export of files are all integrated into one simple app. iRejuvenation allows accurate aesthetic procedures reporting within a few minutes.

A spokesperson for Lifestyle Aesthetics said the new download allows practitioners to establish a ‘cosmetic timeline’ for patients.

“Health authorities have emphasised the importance of traceability,” explained the spokesperson.

“The iRejuvenation Traceability Tool allows the precise recording of product injected. The cross search engine allows you to easily retrieve information stored. This can be searched by patient name, product’s name or the lot number.”

The iRejuvenation Compare Tool also allows medical professionals to show their patients the change in their faces over time.

“Bringing out the impact of cosmetic interventions will build patients loyalty as they can easily see how they have improved from the first treatment,” the spokesperson said.

This new application is a one off cost of £349.99 on the App store and the developers will be continually updating with new features and software – these will be completely free of charge to any professional who has purchased the App. They are only required to do an update.

“We are particularly excited about this new launch,” the spokesperson concluded.

For more information, or to view the demonstration video visit the website www.lifestyleaesthetics.com

Syneron Medical and Unilever Ventures create Iluminage Beauty, a global joint venture in home beauty devices

by

8354888_xxlSyneron Medical Ltd, the global market leader in aesthetic medical devices, and Unilever Ventures,  announced a definitive agreement to form a joint venture in home beauty devices: ‘Iluminage Beauty’.

The aim of the joint venture is to develop and bring to consumers innovative, high performance beauty solutions, empowering them with professional level devices for at-home use.

The joint venture combines the global business and expertise of Syneron’s aesthetic home-use subsidiary, Syneron Beauty Ltd., and Unilever’s luxury beauty subsidiary, Iluminage™ Inc. The joint venture will leverage Unilever’s global experience in the development and marketing of consumer beauty products and Syneron Medical’s expertise in professional aesthetic device technology.

Olivier Garel, Managing Director of Unilever Ventures said:

“We are delighted to enter this partnership and joint venture with Syneron. There is a clear market opportunity to develop home use beauty devices which deliver a step change in benefits for the consumers. Syneron have successfully brought to market some of the most advanced and efficient aesthetic technologies over the last thirteen years. This move gives our combined operations the resources and access to unique patented technologies to grow and expand the business. We look forward to supporting the management team in this exciting next phase of development.”

Shimon Eckhouse, Chief Executive Officer of Syneron Medical, commented:

“Unilever is an ideal partner with consumer brand experience and significant global resources. We believe this joint venture represents the best opportunity to maximize our investment in Syneron Beauty and benefit from its growth potential as part of Iluminage Beauty, while also enabling Syneron Medical to focus resources on its professional aesthetic devices business. The combined Iluminage Beauty business will be well positioned to gain share in the global market, which will build value for our shareholders.”

Fabian Tenenbaum, Chief Executive Officer of Syneron Beauty, added:

“Iluminage has a strong portfolio of products that are complementary to our offerings. Together, we will offer customers around the world some of the most advanced technologies in the fast growing luxury beauty market.”

Under terms of the agreement, Unilever Ventures, the venture capital and private equity arm of Unilever, will invest $25 million and Unilever will also sell and transfer its luxury beauty subsidiary Iluminage to the joint venture, and Syneron Medical will sell and transfer its Syneron Beauty subsidiary and related home-use businesses to the joint venture, creating Iluminage Beauty. Unilever Ventures will hold 51% of Iluminage Beauty and Syneron Medical will retain the remaining 49%.

The companies expect the transaction to close before the end of the year, subject to customary closing conditions and regulatory approvals.